Can I get life insurance with a history of ovarian cancer?

Note: Some links may earn us a commission at no cost to you.

Many people qualify for coverage after ovarian cancer—especially with time in remission and good follow-up care. Insurers weigh your individual history, not just the diagnosis.

📌 Related reading: The Ultimate Guide to Life Insurance Approval, Life Insurance After Cancer: Overview

What Insurers Look At

• Stage & Grade at Diagnosis
  Earlier stage (I–II) and lower grade are viewed more favorably than advanced stage (III–IV) or high-grade serous.
• Histology & Risk Factors
  Epithelial vs. non-epithelial types, BRCA status, genetic testing results, and family history can influence risk.
• Treatment & Outcome
  Surgery (TAH-BSO/debulking), chemotherapy, targeted therapy, radiation—plus pathology and margins.
• Time Since Treatment
  Most carriers want 1–5 years cancer-free; more time = better offers.
• Current Surveillance
  Regular oncology follow-ups, CA-125 trends, and imaging (stable/normal) are reassuring.
• Overall Health
  BMI, blood pressure, cholesterol, diabetes, smoking/nicotine use, etc.
  👉 Related: High Cholesterol and Life Insurance

Typical Underwriting Outcomes (What to Expect)

These are general patterns—each company is different. The right fit matters.

• Stage I, low-grade, completed treatment, 2–3+ years in remission
  Often Standard to mildly Table-rated; some carriers consider Standard Plus with excellent follow-up.
• Stage II, good response, 3–5+ years in remission
  Commonly Table ratings (mild–moderate). May include a temporary flat extra (an added $ per $1,000 of coverage) for a few years.
• Stage III–IV or high-grade with good remission
  Frequently postponed until a longer remission (e.g., 5+ years) and clean surveillance; then table or flat extra possible.
• Recent treatment (<12 months) or active disease
  Usually postponed. Consider guaranteed issue or graded benefit options temporarily.

📌 Learn more: How Underwriters Assess Cancer, What Flat Extras Mean (Cancer)

Ways to Improve Your Approval Odds

• Keep surveillance consistent (on-time oncology visits, documented normal/declining CA-125, stable imaging).
• Share clear documentation: operative reports, pathology, last oncology note, and lab trends.
• Show stability in weight, blood pressure, cholesterol; avoid nicotine.
• Apply to the right carrier: some are demonstrably more flexible with early-stage ovarian cancer than others.
• Time your application: a few additional clean checkups can move you from postponed → approved.

📌 Helpful: Cardiac/Lifestyle Factors: Why They Matter, The Ultimate Guide to Life Insurance Approval

If You Were Declined Before

Declines are not permanent. Two big unlocks:

1. More time in remission (e.g., crossing the 2-year or 5-year mark).
2. Cleaner surveillance (normal CA-125, stable imaging, NED in notes).

Reapply with the right carrier once these change.

Policy Types to Consider

• Traditional Term or Whole Life (best pricing if eligible)
  Great once you’re past the carrier’s remission window.
• Simplified Issue (no exam, health questions only)
  Useful if you’re close to—but not quite past—the preferred waiting period.
• Guaranteed Issue (no questions, graded benefit for first 2 years)
  A bridge when traditional coverage isn’t available yet.

📌 See: Cancer Guide (All Cancers), Ultimate Guide

What to Prepare Before You Apply (Checklist)

• Last oncology visit note (impression/plan)
• Pathology and operative reports (if available)
• CA-125 trend (last 12–24 months)
• Imaging results (CT/PET/MRI summaries)
• List of current meds and dates treatment ended
• Basic vitals (height/weight, BP, lipids)

Bottom Line

An ovarian cancer history doesn’t end your chances of getting life insurance. The keys are time in remission, clean follow-up, and choosing the right insurer. Many applicants secure coverage—sometimes at standard rates—once enough time has passed and surveillance is stable.

💬 Tip: Even if you were declined, a fresh review after more remission time or improved labs can change the outcome.